Skip to main content

Ongoing FDAEvent 99802 (2 days ago)

Baxter Likorall Overhead Lifts

Patients are at some risk for injury if a significant fall/drop were to occur due to this issue.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

Baxter Healthcare Corporation recalled Likorall Overhead Lifts because a potential issue involving motor shaft breakage combined with reduced performance of the Single Fault Safety (SFS) system may lead to instances where the lift strap lowers more quickly than expected during use. Patients are at some risk for injury if a significant fall/drop were to occur due to this issue. The company began the recall on September 14, 2026, and the FDA added it to the Enforcement Report on October 13, 2026.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

Incomplete list: 40 of 53 UDI-DIs shown.

  1. Likorall Overhead Lifts

    Product details from the notice

    Likorall Overhead Lifts Product Code: 3121001 Product Description: LIKORALL 200 Product Code: 3122005 Product Description: LIKORALL 242 ES, NATURAL Product Code: 3122005NA Product Description: LIKORALL 242 ES, NATURAL Product Code: 3122006 Product Description: LIKORALL 242 ES, WHITE Product Code: 3122006NA Product Description: LIKORALL 242 ES, WHITE Product Code: 3122007 Product Description: LIKORALL 242 ES R2R, NATURAL Product Code: 3122007NA Product Description: LIKORALL 242 ES R2R, NATURAL Product Code: 3122008 Product Description: LIKORALL 242 ES R2R, WHITE Product Code: 3122008NA Product Description: LIKORALL 242 ES R2R, WHITE Product Code: 3122009 Product Description: LIKORALL 242 S, NATURAL Product Code: 3122009NA Product Description: LIKORALL 242 S, NATURAL Product Code: 3122010 Product Description: LIKORALL 242 S, WHITE Product Code: 3122011 Product Description: LIKORALL 242 S R2R, NATURAL Product Code: 3122011NA Product Description: LIKORALL 242 S R2R, NATURAL Product Code: 3122012 Product Description: LIKORALL 242 S R2R, WHITE Product Code: 3122012NA Product Description: LIKORALL 242 S R2R, WHITE Product Code: 3122501 Product Description: LIKORALL 250 ES, NATURAL Product Code: 3122501NA Product Description: LIKORALL 250 ES, NATURAL Product Code: 3122502 Product Description: LIKORALL 250 ES, WHITE Product Code: 3122502NA Product Description: LIKORALL 250 ES, WHITE Product Code: 3123001 Product Description: LIKORALL 243 ES Product Code: 3123001NA Product Description: LIKORALL 243 ES Product Code: 3123002 Product Description: LIKORALL 243 ES, WHITE Product Code: 3123002NA Product Description: LIKORALL 243 ES, WHITE Product Code: 3124050 Product Description: LIKORALL 250 S, IRC

    UDI-DI
    • 00887761981911
    • 3122005
    • 242
    • 00887761979710
    • 3122005NA
    • 00887761979727
    • 3122006
    • 00887761979734
    • 3122006NA
    • 00887761979741
    • 3122007
    • R2R
    • 00887761979758
    • 3122007NA
    • 00887761979765
    • 3122008
    • 00887761979772
    • 3122008NA
    • 00887761979789
    • 3122009
    • 00887761979796
    • 3122009NA
    • 00887761979802
    • 3122010
    • 00887761979819
    • 3122011
    • 00887761979444
    • 3122011NA
    • 00887761979451
    • 3122012
    • 00887761979468
    • 3122012NA
    • 00887761979475
    • 3122501
    • 250
    • 00887761979482
    • 3122501NA
    • 00887761979499
    • 3122502
    • 00887761979505

Details

Company began the recall
Event ID
99802
Company
Baxter Healthcare Corporation
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

All recalls from Baxter Healthcare Corporation

Summary by Recall Canary, written with AI · summary updated Oct 14, 2026 · primary source: U.S. Food and Drug Administration